Stocktoria
Fulcrum Therapeutics, Inc. FULC
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-07-18
Fulcrum Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,798,522 | $29.8M | 7.21% |
| D. E. Shaw & Co., Inc. | 3,044,385 | $11.1M | 4.57% |
| CITADEL ADVISORS LLC | 2,941,705 | $10.8M | 4.42% |
| RENAISSANCE TECHNOLOGIES LLC | 1,647,800 | $6.0M | 2.47% |
| MILLENNIUM MANAGEMENT LLC | 1,485,803 | $5.4M | 2.23% |
| AQR CAPITAL MANAGEMENT LLC | 1,103,261 | $4.0M | 1.66% |
| TWO SIGMA INVESTMENTS, LP | 812,766 | $3.0M | 1.22% |
| Point72 Asset Management, L.P. | 651,427 | $2.4M | 0.98% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.